NCT03882671Completed
Development of a Minimally Invasive Seizure Gauge
Source: ClinicalTrials.gov · Last updated 15 May 2025
Brief summary (registry, in English)
The researchers are trying to assess changes in physiological signals before and during seizures.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 11 Mar 2019
- Start date
- 1 Jan 2019
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Seer Medical Pty Ltd
- Diseases
- Epilepsy
- NCT number
- NCT03882671
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 1 Jan 2019 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cognitive or psychiatric condition rendering patient unable to cooperate with data collection, or manage and recharge smart watch and tablet computer devices.
Who the study is looking for
- Patients with epilepsy undergoing scalp EEG for clinical care, or an implanted device capable of monitoring brain activity and identifying seizures
- Patients of age 18 or above
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Seer Medical Coordinator of this site? Confirm its status | Melbourne | Australia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.